Recruiting at 1 site No phase Stroke

Stroke study: NoNo

Official title Self-Administered Gaming and Exercise at Home (SAGEH)

ClinicalTrials.gov ID: NCT05929027

What this study is testing

What it's testing
The study wants to see whether adding self‑administered hand therapy to usual care improves hand dexterity and coordination after a stroke.
Who it's for
Adults who have had a stroke and have weakness in their hands.
What's involved
Participants will do daily hand‑therapy exercises or games at home in addition to their regular care, and researchers will measure their hand function.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 and older

You may be able to join if

  • Age 21 years and over
  • Stroke confirmed by CT or MRI within the previous 6 weeks.
  • Arm and/or hand impairment induced by the stroke.
  • Meet JSTTEP criteria and are enrolled in JSTTEP.
  • Admitted to the Johns Hopkins Hospital (JHH) inpatient stroke service.

You likely can't join if

  • Arm impairment that is too severe (FM-UE \< 40) on day of baseline testing prior to beginning of the study.
  • Recent Botox injection to upper limb (since stroke onset).
  • History of physical or neurological condition that interferes with study procedures or assessment of motor function (e.g.
  • Terminal illness with life expectancy \< 6 months.
  • Inability to sit in a chair and perform hand exercises for 20 minutes at the time.
  • Cognitive impairment, with score on Montreal Cognitive Assessment (MoCA) ≤ 20.
See the full eligibility criteria
Who can join
  • Age 21 years and over
  • Stroke confirmed by CT or MRI within the previous 6 weeks.
  • Arm and/or hand impairment induced by the stroke.
  • Meet JSTTEP criteria and are enrolled in JSTTEP.
  • Admitted to the Johns Hopkins Hospital (JHH) inpatient stroke service.
  • Proficient in speaking and reading English.
  • Willing and capable to contacted remotely for all necessary telemedicine contacts.
  • No history of prior ischemic or hemorrhagic stroke with associated motor deficits (prior stroke with no upper limb motor symptoms is allowed)
  • Ability to give informed consent.
What rules you out
  • Arm impairment that is too severe (FM-UE \< 40) on day of baseline testing prior to beginning of the study.
  • Recent Botox injection to upper limb (since stroke onset).
  • History of physical or neurological condition that interferes with study procedures or assessment of motor function (e.g. severe arthritis, severe neuropathy, Parkinson's disease).
  • Terminal illness with life expectancy \< 6 months.
  • Inability to sit in a chair and perform hand exercises for 20 minutes at the time.
  • Cognitive impairment, with score on Montreal Cognitive Assessment (MoCA) ≤ 20.
  • Social and/or personal circumstances that prevent telemedicine follow-up.

The study team makes the final eligibility decision.

Where it is enrolling

  • Baltimore, Maryland, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Baltimore, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.